{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:34:50Z","timestamp":1773221690768,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04152-y","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:26:32Z","timestamp":1770355592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between steatotic liver disease (MASLD, met-ALD, and ALD) with preserved ratio impaired spirometry: a population-based study"],"prefix":"10.1186","volume":"26","author":[{"given":"Sumin","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunji","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaejun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"1","key":"4152_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12931-022-02113-7","volume":"23","author":"J Lu","year":"2022","unstructured":"Lu J, Ge H, Qi L, Zhang S, Yang Y, Huang X, Li M. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics. Respir Res. 2022;23(1):309.","journal-title":"Respir Res"},{"key":"4152_CR2","doi-asserted-by":"crossref","unstructured":"Wan ES, Balte P, Schwartz JE, Bhatt SP, Cassano PA, Couper D, Daviglus ML, Dransfield MT, Gharib SA, Jacobs DR, editors. Jr. : Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults. Jama. 2021; 326(22):2287\u20132298.","DOI":"10.1001\/jama.2021.20939"},{"issue":"1","key":"4152_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","volume":"15","author":"ES Wan","year":"2014","unstructured":"Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, Beaty TH, Han MK, Curtis JL, Curran-Everett D, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15(1):89.","journal-title":"Respir Res"},{"issue":"1","key":"4152_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12931-024-02841-y","volume":"25","author":"CJ Cadham","year":"2024","unstructured":"Cadham CJ, Oh H, Han MK, Mannino D, Cook S, Meza R, Levy DT, S\u00e1nchez-Romero LM. The prevalence and mortality risks of PRISm and COPD in the united States from NHANES 2007\u20132012. Respir Res. 2024;25(1):208.","journal-title":"Respir Res"},{"issue":"2","key":"4152_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.chest.2024.08.026","volume":"167","author":"L Cestelli","year":"2025","unstructured":"Cestelli L, Johannessen A, Gulsvik A, Stavem K, Nielsen R. Risk Factors, Morbidity, and mortality in association with preserved ratio impaired spirometry and restrictive spirometric pattern: clinical relevance of preserved ratio impaired spirometry and restrictive spirometric pattern. Chest. 2025;167(2):548\u201360.","journal-title":"Chest"},{"issue":"1","key":"4152_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000517599","volume":"101","author":"J Kim","year":"2022","unstructured":"Kim J, Lee CH, Lee HY, Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean National health and nutrition examination survey IV-VI. Respiration. 2022;101(1):25\u201333.","journal-title":"Respiration"},{"key":"4152_CR7","doi-asserted-by":"crossref","unstructured":"Chapman R, Cheng D, Azimbagirad M, Wang S, Yamada D, Gupta RK, Hurst JR, Jacob J. Associations of preserved ratio impaired spirometry (PRISm) with Cardio-Metabolic comorbidities: A systematic review & Meta-analysis. ERJ Open Res 2025;11(6):00396\u20132025.","DOI":"10.1183\/23120541.00396-2025"},{"key":"4152_CR8","doi-asserted-by":"crossref","unstructured":"Wijnant SRA, De Roos E, Kavousi M, Stricker BH, Terzikhan N, Lahousse L, Brusselle GG. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study. Eur Respir J. 2020;55(1):1901217.","DOI":"10.1183\/13993003.01217-2019"},{"issue":"1","key":"4152_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ije\/dyt228","volume":"43","author":"S Kweon","year":"2014","unstructured":"Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. Data resource profile: the Korea National health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69\u201377.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"4152_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"6","key":"4152_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"7","key":"4152_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"4152_CR13","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/s41598-022-06205-8","volume":"12","author":"JE Han","year":"2022","unstructured":"Han JE, Shin HB, Ahn YH, Cho HJ, Cheong JY, Park B, Kim SS. Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. Sci Rep. 2022;12(1):2538.","journal-title":"Sci Rep"},{"issue":"4","key":"4152_CR14","doi-asserted-by":"publisher","first-page":"e16159","DOI":"10.1111\/liv.16159","volume":"45","author":"J Bilson","year":"2025","unstructured":"Bilson J, Hydes TJ, McDonnell D, Buchanan RM, Scorletti E, Mantovani A, Targher G, Byrne CD. Impact of metabolic syndrome traits on kidney disease risk in individuals with MASLD: A UK biobank study. Liver Int. 2025;45(4):e16159.","journal-title":"Liver Int"},{"issue":"6","key":"4152_CR15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","volume":"22","author":"M Kalligeros","year":"2024","unstructured":"Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the united states: NHANES 2017\u20132020. Clin Gastroenterol Hepatol. 2024;22(6):1330\u2013e13321334.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4152_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jhep.2021.08.016","volume":"75","author":"MJ Nielsen","year":"2021","unstructured":"Nielsen MJ, Leeming DJ, Goodman Z, Friedman S, Frederiksen P, Rasmussen DGK, Vig P, Seyedkazemi S, Fischer L, Torstenson R, et al. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol. 2021;75(6):1292\u2013300.","journal-title":"J Hepatol"},{"issue":"4","key":"4152_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.36519\/idcm.2023.276","volume":"5","author":"D G\u00fcr-Altunay","year":"2023","unstructured":"G\u00fcr-Altunay D, Y\u00fcr\u00fck-Atasoy P. How successful are APRI and FIB-4 scores in predicting liver fibrosis in chronic hepatitis B patients? Infect Dis Clin Microbiol. 2023;5(4):332\u201340.","journal-title":"Infect Dis Clin Microbiol"},{"issue":"10464","key":"4152_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"key":"4152_CR19","doi-asserted-by":"publisher","first-page":"1415484","DOI":"10.3389\/fnut.2024.1415484","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen S, Tian C, Wang Q, Yang Z, Che W, Li Y, Luo Y. Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007\u20132018. Front Nutr. 2024;11:1415484.","journal-title":"Front Nutr"},{"issue":"6","key":"4152_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.diabet.2019.04.008","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Lonardo A, Vinco G, Zoppini G, Lippi G, Bonora E, Loomba R, Tilg H, Byrne CD, Fabbri L, et al. Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis. Diabetes Metab. 2019;45(6):536\u201344.","journal-title":"Diabetes Metab"},{"issue":"4","key":"4152_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000535943","volume":"13","author":"GA Kim","year":"2024","unstructured":"Kim GA, Jeong S, Jang H, Lee DH, Joo SK, Kim W. Metabolic Dysfunction-Associated steatotic liver disease and metabolic Dysfunction-Associated steatotic liver disease with increased alcohol intake increase the risk of developing hepatocellular carcinoma and incident or decompensated cirrhosis: A Korean nationwide study. Liver Cancer. 2024;13(4):426\u201337.","journal-title":"Liver Cancer"},{"issue":"2","key":"4152_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.14309\/ajg.0000000000002920","volume":"120","author":"B Yun","year":"2025","unstructured":"Yun B, Park H, Ahn SH, Oh J, Kim BK, Yoon JH. Liver cancer risk across metabolic Dysfunction-Associated steatotic liver disease and\/or alcohol: A nationwide study. Am J Gastroenterol. 2025;120(2):410\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"4152_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","volume":"10","author":"C Celsa","year":"2025","unstructured":"Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, et al. Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(11):998\u20131012.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"4152_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1164\/rccm.202304-0765LE","volume":"208","author":"C Schiffers","year":"2023","unstructured":"Schiffers C, Mraz T, Breyer M-K, Hartl S, Breyer-Kohansal R, Wouters EFM. Restrictive spirometry or prism: does it matter? Am J Respir Crit Care Med. 2023;208(8):905\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4152_CR25","doi-asserted-by":"publisher","first-page":"2000354","DOI":"10.1183\/13993003.00354-2020","volume":"55","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant SRA, Lahousse L, Brusselle GG. The global significance of prism: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J. 2020;55(4):2000354.","journal-title":"Eur Respir J"},{"key":"4152_CR26","doi-asserted-by":"crossref","unstructured":"Jesus FR, Moraes ACS, da Silva ILN, Passos FC, Salles C, Neves M, Baccan GC. Analysis of endocrine and inflammatory markers in preserved ratio impaired spirometry. Med Sci (Basel). 2024;12(2):18.","DOI":"10.3390\/medsci12020018"},{"issue":"7","key":"4152_CR27","doi-asserted-by":"publisher","first-page":"e0307302","DOI":"10.1371\/journal.pone.0307302","volume":"19","author":"H Choi","year":"2024","unstructured":"Choi H, Oak CH, Jung MH, Jang TW, Nam SJ, Yoon T. Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): nationwide population-based survey between 2010 and 2019. PLoS ONE. 2024;19(7):e0307302.","journal-title":"PLoS ONE"},{"issue":"4","key":"4152_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/hep.23622","volume":"51","author":"L Valenti","year":"2010","unstructured":"Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, et al. Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(4):1209\u201317.","journal-title":"Hepatology"},{"issue":"4","key":"4152_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.24491","volume":"54","author":"N Bhala","year":"2011","unstructured":"Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54(4):1208\u201316.","journal-title":"Hepatology"},{"issue":"11","key":"4152_CR30","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1111\/liv.13860","volume":"38","author":"CH Lee","year":"2018","unstructured":"Lee CH, Choi SH, Chung GE, Park B, Kwak MS. Nonalcoholic fatty liver disease is associated with decreased lung function. Liver Int. 2018;38(11):2091\u2013100.","journal-title":"Liver Int"},{"issue":"2","key":"4152_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14218\/JCTH.2022.00103","volume":"10","author":"DM Van Rooyen","year":"2022","unstructured":"Van Rooyen DM, Ayonrinde OT. Impaired pulmonary function as a potential contributor to reduced exercise capacity associated with MAFLD. J Clin Transl Hepatol. 2022;10(2):181\u20133.","journal-title":"J Clin Transl Hepatol"},{"issue":"13","key":"4152_CR32","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/15384101.2016.1152435","volume":"15","author":"E Makarev","year":"2016","unstructured":"Makarev E, Izumchenko E, Aihara F, Wysocki PT, Zhu Q, Buzdin A, Sidransky D, Zhavoronkov A, Atala A. Common pathway signature in lung and liver fibrosis. Cell Cycle. 2016;15(13):1667\u201373.","journal-title":"Cell Cycle"},{"issue":"1","key":"4152_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12876-025-03770-w","volume":"25","author":"P Yan","year":"2025","unstructured":"Yan P, Yu X, Chen Z, Lan L, Kang J, Zhao B, Liu D. Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases. BMC Gastroenterol. 2025;25(1):191.","journal-title":"BMC Gastroenterol"},{"key":"4152_CR34","doi-asserted-by":"publisher","first-page":"627396","DOI":"10.3389\/fgene.2020.627396","volume":"11","author":"C Gu","year":"2020","unstructured":"Gu C, Shi X, Dang X, Chen J, Chen C, Chen Y, Pan X, Huang T. Identification of common genes and pathways in eight fibrosis diseases. Front Genet. 2020;11:627396.","journal-title":"Front Genet"},{"key":"4152_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"key":"4152_CR36","doi-asserted-by":"crossref","unstructured":"Antar SA, Ashour NA, Marawan ME, Al-Karmalawy AA. Fibrosis: Types, Effects, Markers, mechanisms for disease Progression, and its relation with oxidative Stress, Immunity, and inflammation. Int J Mol Sci. 2023;24(4):4004 .","DOI":"10.3390\/ijms24044004"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04152-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04152-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04152-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:16:37Z","timestamp":1773144997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04152-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4152"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04152-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the Korea Disease Control and Prevention Agency (2010-02CON-21-C, 2011-02CON06-C, 2012-01EXP-01\u20132\u00a0C, 2013-07CON-03\u20134\u00a0C, 2013-12EXP-03\u20135\u00a0C, 2018-01-03-P-A, and 2018-01-03-C-A). Written informed consent was obtained from all individuals. The study protocol and was conducted in accordance with the principles of the Declaration of Helsinki. All procedures were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}